These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9771955)

  • 1. Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography.
    Souid AK; Newton GL; Dubowy RL; Fahey RC; Bernstein ML
    Cancer Chemother Pharmacol; 1998; 42(5):400-6. PubMed ID: 9771955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of amifostine.
    Shaw LM; Bonner H; Lieberman R
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):18-22. PubMed ID: 8783662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography.
    Bonner HS; Shaw LM
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 739(2):357-62. PubMed ID: 10755379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue levels of WR-1065, the active metabolite of amifostine (Ethyol), are equivalent following intravenous or subcutaneous administration in cynomolgus monkeys.
    Bachy CM; Fazenbaker CA; Kifle G; McCarthy MP; Cassatt DR
    Oncology; 2004; 67(3-4):187-93. PubMed ID: 15557777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma.
    Korst AE; Vermorken JB; van der Vijgh WJ
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):167-74. PubMed ID: 9200531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.
    Souid AK; Fahey RC; Dubowy RL; Newton GL; Bernstein ML
    Cancer Chemother Pharmacol; 1999; 44(6):498-504. PubMed ID: 10550571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.
    Souid AK; Fahey RC; Aktas MK; Sayin OA; Karjoo S; Newton GL; Sadowitz PD; Dubowy RL; Bernstein ML
    Drug Metab Dispos; 2001 Nov; 29(11):1460-6. PubMed ID: 11602522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equilibrium dialysis studies of the binding of radioprotector compounds to DNA.
    Smoluk GD; Fahey RC; Ward JF
    Radiat Res; 1986 Aug; 107(2):194-204. PubMed ID: 3018831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient.
    Korst AE; Gall HE; Vermorken JB; van der Vijgh WJ
    Cancer Chemother Pharmacol; 1996; 39(1-2):162-6. PubMed ID: 8995515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721).
    Thompson DC; Wyrick SD; Holbrook DJ; Chaney SG
    Biochem Pharmacol; 1995 Oct; 50(9):1413-9. PubMed ID: 7503792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of S-35 labeled WR-2721 and its metabolites in biological fluids.
    Anderson KW; Krohn KA; Grunbaum Z; Phillips RB; Mahler PA; Menard TW; Spence AM; Rasey JS
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1511-5. PubMed ID: 6090353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of WR-1065 and WR-33278 by liquid chromatography with electrochemical detection.
    Pendergrass JA; Srinivasan V; Kumar KS; Jackson WE; Seed TM
    J AOAC Int; 2002; 85(3):551-4. PubMed ID: 12083246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pharmacokinetics of WR-2721.
    Shaw LM; Turrisi AT; Glover DJ; Bonner HS; Norfleet AL; Weiler C; Kligerman MM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1501-4. PubMed ID: 3019968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic pathways of WR-2721 (ethyol, amifostine) in the BALB/c mouse.
    Shaw LM; Bonner HS; Brown DQ
    Drug Metab Dispos; 1994; 22(6):895-902. PubMed ID: 7895607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of amifostine and its metabolites in patients.
    Korst AE; Eeltink CM; Vermorken JB; van der Vijgh WJ
    Eur J Cancer; 1997 Aug; 33(9):1425-9. PubMed ID: 9337685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPLC assay for 2-(3-aminopropylamino)ethanethiol (WR-1065) in plasma.
    McGovern EP; Swynnerton NF; Steele PD; Mangold DJ
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1517-20. PubMed ID: 6480444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a method for measuring the radioprotective metabolite WR-1065 in plasma using chemical derivatization combined with UHPLC-MS/MS.
    Simon ES; Reyna D; Lister RJ; Harteg C; Lipka E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():82-89. PubMed ID: 29482122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).
    Khodarev NN; Kataoka Y; Murley JS; Weichselbaum RR; Grdina DJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):553-63. PubMed ID: 15380592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: results of a phase I study.
    Fiorentini G; Giovanis P; Leoni M; De Giorgi U; Cariello A; Dazzi C; Caldeo A
    Hepatogastroenterology; 2001; 48(38):313-6. PubMed ID: 11379297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostine.
    Levi M; DeRemer SJ; Dou C; Ensminger WD; Smith DE
    Biopharm Drug Dispos; 2004 Jan; 25(1):27-35. PubMed ID: 14716750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.